- +971 50 312 9316
- info@menovivreclinic.com
- Mon-Fri: 8AM - 7PM | Sun: 8AM - 4PM
High-risk pregnancy management, early pregnancy assessment, recurrent miscarriage evaluation, complex obstetric monitoring
Female hormone profile (FSH, LH, oestradiol, progesterone), androgen panel where PCOS is suspected, thyroid function (TSH, free T3, free T4), and metabolic markers including fasting glucose, HbA1c, and insulin resistance indicators.
Transvaginal and pelvic ultrasound for fibroids, cysts, and endometrial changes; ovarian morphology assessment; endometrial thickness evaluation in cases of abnormal bleeding; and cervical screening including Pap smear and HPV testing where indicated.
Ovulation tracking, cycle evaluation, ovarian reserve indicators, and early fertility work-up for patients presenting with conception delay or a history of miscarriage.
Vaginal swabs for bacterial vaginosis, yeast infections, and STI screening where indicated; urinalysis for symptoms that overlap with urinary tract involvement.
Early pregnancy risk stratification, monitoring protocol design, and coordination with relevant specialties for complex obstetric presentations.
A detailed clinical assessment covering your gynaecological, fertility, hormonal, and symptom history. Dr. Uloma maps the full pattern of your symptoms, not just the most recent presentation.
Targeted investigations based on clinical suspicion, including hormonal panels, imaging, and where relevant, infection screening. Early symptom management is initiated where appropriate.
Diagnosis refinement and treatment initiation. Patients typically begin to notice measurable improvement in pain, bleeding, or cycle regulation within this window.
Symptom stabilisation. Fertility or hormonal optimisation begins to show measurable clinical improvement.
Ongoing monitoring for conditions with recurrence risk such as endometriosis and fibroids, fertility or pregnancy pathway management, and preventive gynaecological health planning across the reproductive life span.
Significant menstrual pain that disrupts daily life is not a normal baseline. It is one of the most common presentations of endometriosis, a condition that affects an estimated 1 in 10 women and frequently goes undiagnosed for years. Pain that limits function warrants clinical investigation, not reassurance.
Cycle irregularity can indicate PCOS, thyroid dysfunction, hormonal imbalance, or early perimenopausal transition. Waiting without investigation delays diagnosis and, in some cases, affects fertility outcomes.
Many presentations of difficulty conceiving have a treatable or improvable underlying cause. Early assessment often reveals specific, addressable factors including ovulation issues, hormonal imbalance, or structural concerns, each with a clear management pathway.
Changes in discharge can indicate bacterial vaginosis, yeast overgrowth, hormonal shifts, or conditions requiring further investigation. Persistent or unusual changes should be assessed rather than self-managed.
Post-menopausal bleeding is always clinically significant. It requires prompt evaluation to rule out endometrial pathology and should never be attributed to hormonal fluctuation without investigation.
A: Dr. Uloma is a Fellow of the Royal College of Obstetricians and Gynaecologists (FRCOG) specialising in complex gynaecological conditions, endometriosis, fertility, minimally invasive gynaecologic surgery, and high-risk pregnancy. She has particular expertise in presentations where symptoms overlap across multiple systems and a clear diagnosis has not previously been established.
A: Yes. Endometriosis and chronic pelvic pain are a core area of Dr. Uloma’s practice, spanning both medical and surgical management. Her minimally invasive surgical expertise means she can offer procedural intervention where clinically indicated, alongside medical treatment.
A: Yes. Fertility evaluation and reproductive assessment are central to her practice, including ovulation assessment, ovarian reserve evaluation, early fertility work-up, and management of conditions such as endometriosis or PCOS that affect conception.
A: Yes. High-risk obstetric care is a specific area of expertise, including early pregnancy risk stratification, monitoring of complex obstetric cases, and coordination with relevant specialties where required.
A: Yes. Many of the patients Dr. Uloma sees have previously been told their symptoms are within normal range. Significant menstrual pain, persistent cycle irregularity, unexplained pelvic discomfort, and fertility delay all warrant thorough clinical investigation. A structured assessment will either confirm there is nothing concerning or identify a treatable cause.
A: Yes. Dr. Uloma functions as a clinical anchor for complex presentations and coordinates directly with Menovivre’s functional medicine, hormonal health, and nutrition teams where integrated care is indicated.
